Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium Depth and Postoperative Residual Neuromuscular Block in Ambulatory Arthroscopic Surgery
ChiCTR2100053039Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of rocuronium in disorders of knee (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: incidence of postoperative residual neuromuscular block and nTOFr during extubation. Started Dec 2021; status: recruiting.
02
Drugs
rocuronium
03
Conditions
disorders of knee
Beyond the preview
Go deeper on ChiCTR2100053039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053039.